GLP-1 (Semaglutide)
Metabolic age reduction; visceral fat clearance; cardiovascular risk reduction; neuroinflammation suppression
AOD-9604
AdjacentResearch ongoing — see primary literature for current evidence.
Clinical Decision Framework
When evaluating GLP-1 (Semaglutide) versus AOD-9604 for biological age reduction, the primary consideration is the specific hallmark of aging being targeted. While both compounds offer systemic healthspan benefits, their mechanisms of action are distinct.
When to prioritize GLP-1 (Semaglutide):
Select GLP-1 (Semaglutide) when the primary clinical objective aligns with its core mechanism: glp-1 receptor agonist that delays gastric emptying and activates hypothalamic satiety centers to suppress appetite.. This is particularly relevant for protocols focused on significant weight loss via appetite suppression and metabolic improvement..
When to prioritize AOD-9604:
Conversely, AOD-9604 is the superior choice when targeting modified c-terminal fragment of human growth hormone that stimulates lipolysis via beta-3 adrenergic receptors without gh side effects., making it the preferred agent for targeted fat metabolism and body composition improvement without gh-related side effects..
Begin Your Age Reversal Protocol for GLP-1 (Semaglutide) or AOD-9604
Alukard provides physician-supervised longevity protocols with GMP-certified compounds, biomarker testing, and personalized biological age reduction programs.
HIPAA Compliant · GMP Certified · Physician Supervised · Biomarker Testing